Research Article
Effect of Xueniao Capsule on Escherichia coli-Induced Acute Pyelonephritis Rats by 1H NMR-Based Metabolomic Approach
Table 2
Comparison of the integral levels of metabolites in eight groups.
| Metabolites | δ (ppm) | VIP | APN | Change trend | Recovery rates (%) | APN + N | APN + XNC | APN + PE | APN + EA | APN + BU | APN + W | APN + N | APN + XNC | APN + PE | APN + EA | APN + BU | APN + W |
| Lactate | 1.33 | 9.04 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 67.81 | 61.72 | 18.01 | 18.11 | 28.89 | 37.57 | Choline | 3.21 | 6.52 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 53.10 | 47.73 | 19.99 | 24.16 | 36.47 | 16.76 | Glutamate | 2.36 | 2.83 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 26.01 | 40.02 | 27.39 | 45.94 | 9.32 | 17.08 | Fumarate | 6.53 | 1.01 | ↑ | ↓ | ↓ | — | ↓ | — | ↓ | 59.75 | 69.50 | — | 80.91 | — | 42.74 | Succinate | 2.41 | 1.92 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 111.21 | 124.09 | 71.95 | 53.85 | 114.45 | 53.89 | Glutamine | 2.13 | 1.60 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 59.53 | 28.35 | 41.81 | 46.61 | 52.20 | 46.14 | Acetate | 1.93 | 6.41 | ↑ | ↓ | ↓ | — | — | — | — | 62.80 | 84.94 | — | — | — | — | Myo-inositol | 3.53 | 1.53 | ↑ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | 42.30 | 35.81 | 24.93 | 26.96 | 30.34 | 6.22 | Ethanolamine | 3.15 | 1.28 | ↑ | — | ↓ | — | — | — | — | — | 138.10 | — | — | — | — | Valine | 1.05 | 1.27 | ↓ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | 113.45 | 117.47 | 83.79 | 73.56 | 90.46 | 81.38 | TMA | 2.88 | 1.05 | ↓ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | 92.11 | 82.73 | 42.64 | 86.78 | 46.48 | 89.34 | DMG | 2.91 | 1.14 | ↓ | ↑ | ↑ | — | ↑ | — | ↑ | 36.92 | 42.31 | — | 23.08 | — | 55 | Alanine | 1.49 | 1.14 | ↓ | ↑ | — | ↑ | — | — | ↑ | 44.35 | — | 7.17 | — | — | 9.44 | Serine | 3.97 | 1.74 | ↓ | ↑ | ↑ | — | — | — | — | 55.13 | 26.97 | — | — | — | — | Betaine | 3.91 | 3.28 | ↓ | ↑ | — | — | — | — | ↑ | 27.52 | — | — | — | — | 29.99 | Aspartate | 2.81 | 2.33 | ↓ | ↑ | — | — | — | — | — | 144.68 | — | — | — | — | — | Efficacy index (EI) | 996.67 | 899.74 | 337.68 | 479.96 | 408.61 | 485.55 |
|
|
Compared with the NS group, , ; compared with the APN group, , . |